Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fausto Petrelli

Showing results (271-280 of 304) with videos related to

Pageof 31
Sort By:
BMC Cancer|February 1, 2023
Final analysis of the phase 3 randomized clinical trial comparing HD201 vs. referent trastuzumab in patients with ERBB2-positive breast cancer treated in the neoadjuvant settingXavier Pivot, Alexey Georgievitch Manikhas, Volodymyr Shamrai, et al.
Journal of Geriatric Oncology|April 18, 2020
Efficacy of Eribulin mesylate in older patients with breast cancer: A pooled analysis of clinical trial and real-world dataRebecca Pedersini, Pierluigi di Mauro, Vito Amoroso, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 22, 2019
Adjuvant radiotherapy for Merkel cell carcinoma: A systematic review and meta-analysisFausto Petrelli, Antonio Ghidini, Martina Torchio, et al.
JAMA Oncology|July 13, 2023
Efficacy of Metronomic Oral Vinorelbine, Cyclophosphamide, and Capecitabine vs Weekly Intravenous Paclitaxel in Patients With Estrogen Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer: Final Results From the Phase 2 METEORA-II Randomized Clinical TrialElisabetta Munzone, Meredith M Regan, Saverio Cinieri, et al.
Cancers|August 28, 2025
Baseline Hemostatic Biomarker Assessment Identifies Breast Cancer Patients at High Risk for Venous Thromboembolism During ChemotherapyMarina Marchetti, Patricia Gomez-Rosas, Laura Russo, et al.
World Journal of Clinical Oncology|December 15, 2021
First-line pazopanib in patients with advanced non-clear cell renal carcinoma: An Italian case seriesSebastiano Buti, Melissa Bersanelli, Francesco Massari, et al.
Scientific Reports|January 23, 2023
Exploratory analysis of the effect of a dexamethasone-sparing regimen for prophylaxis of cisplatin-induced emesis on food intake (LUNG-NEPA study)Luigi Celio, Diego Cortinovis, Alessio Aligi Cogoni, et al.
Cancers|September 23, 2022
Thrombin Generation and D-Dimer for Prediction of Disease Progression and Mortality in Patients with Metastatic Gastrointestinal CancerCinzia Giaccherini, Cristina Verzeroli, Laura Russo, et al.
NPJ Breast Cancer|July 20, 2022
PREDICT underestimates survival of patients with HER2-positive early-stage breast cancerElisa Agostinetto, Lieveke Ameye, Samuel Martel, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|February 15, 2021
Validation of the Role of Thrombin Generation Potential by a Fully Automated System in the Identification of Breast Cancer Patients at High Risk of Disease RecurrencePatricia Gomez-Rosas, Marina Pesenti, Cristina Verzeroli, et al.
Pageof 31

Showing results (271-280 of 304) with videos related to

Sort By:
Pageof 31
BMC Cancer|February 1, 2023
Final analysis of the phase 3 randomized clinical trial comparing HD201 vs. referent trastuzumab in patients with ERBB2-positive breast cancer treated in the neoadjuvant settingXavier Pivot, Alexey Georgievitch Manikhas, Volodymyr Shamrai, et al.
Journal of Geriatric Oncology|April 18, 2020
Efficacy of Eribulin mesylate in older patients with breast cancer: A pooled analysis of clinical trial and real-world dataRebecca Pedersini, Pierluigi di Mauro, Vito Amoroso, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 22, 2019
Adjuvant radiotherapy for Merkel cell carcinoma: A systematic review and meta-analysisFausto Petrelli, Antonio Ghidini, Martina Torchio, et al.
JAMA Oncology|July 13, 2023
Efficacy of Metronomic Oral Vinorelbine, Cyclophosphamide, and Capecitabine vs Weekly Intravenous Paclitaxel in Patients With Estrogen Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer: Final Results From the Phase 2 METEORA-II Randomized Clinical TrialElisabetta Munzone, Meredith M Regan, Saverio Cinieri, et al.
Cancers|August 28, 2025
Baseline Hemostatic Biomarker Assessment Identifies Breast Cancer Patients at High Risk for Venous Thromboembolism During ChemotherapyMarina Marchetti, Patricia Gomez-Rosas, Laura Russo, et al.
World Journal of Clinical Oncology|December 15, 2021
First-line pazopanib in patients with advanced non-clear cell renal carcinoma: An Italian case seriesSebastiano Buti, Melissa Bersanelli, Francesco Massari, et al.
Scientific Reports|January 23, 2023
Exploratory analysis of the effect of a dexamethasone-sparing regimen for prophylaxis of cisplatin-induced emesis on food intake (LUNG-NEPA study)Luigi Celio, Diego Cortinovis, Alessio Aligi Cogoni, et al.
Cancers|September 23, 2022
Thrombin Generation and D-Dimer for Prediction of Disease Progression and Mortality in Patients with Metastatic Gastrointestinal CancerCinzia Giaccherini, Cristina Verzeroli, Laura Russo, et al.
NPJ Breast Cancer|July 20, 2022
PREDICT underestimates survival of patients with HER2-positive early-stage breast cancerElisa Agostinetto, Lieveke Ameye, Samuel Martel, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|February 15, 2021
Validation of the Role of Thrombin Generation Potential by a Fully Automated System in the Identification of Breast Cancer Patients at High Risk of Disease RecurrencePatricia Gomez-Rosas, Marina Pesenti, Cristina Verzeroli, et al.
Pageof 31